Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X:
“Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention. The gut microbiota plays a key role in irAE development, especially ICI-induced colitis. Microbial biomarkers and therapies like FMT offer new hope for managing irAEs.”
Title: Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention
Authors: Ya-Qi Gao, Yong-Jie Tan, Jing-Yuan Fang
Read the Full Article.
More posts featuring Diego A. Díaz García.
